14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRQR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in ProQR Therapeutics N.V. stock price on Monday moving 15.18% between high and low
(Updated on Apr 15, 2024)

Sell candidate since Apr 12, 2024 Loss -7.05% PDF

The ProQR Therapeutics N.V. stock price fell by -7.05% on the last day (Monday, 15th Apr 2024) from $2.20 to $2.05. During the last trading day the stock fluctuated 15.18% from a day low at $1.91 to a day high of $2.20. The price has been going up and down for this period, and there has been a -6.62% loss for the last 2 weeks. Volume has increased on the last day by 195 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 319 thousand shares were bought and sold for approximately $653.20 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.95 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.09% during the next 3 months and, with a 90% probability hold a price between $2.05 and $3.14 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

PRQR Signals & Forecast

There are few to no technical positive signals at the moment. The ProQR Therapeutics N.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.22 and $2.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -14.44%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ProQR Therapeutics N.V. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.94 and $1.93. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ProQR Therapeutics N.V. finds support just below today's level at $1.94. If this is broken, then the next support from accumulated volume will be at $1.93 and $1.90.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.290 between high and low, or 15.18%. For the last week, the stock has had daily average volatility of 9.62%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRQR) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect ProQR Therapeutics N.V. to open at $2.05, and during the day (based on 14 day Average True Range), to move between $1.87 and $2.22, which gives a possible trading interval of +/-$0.172 (+/-8.41%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 16.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.09 (2.20%) than the support at $1.94 (5.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProQR Therapeutics N.V. stock A Buy?

The ProQR Therapeutics N.V. stock holds several negative signals and despite the positive trend, we believe ProQR Therapeutics N.V. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.572 Sell Candidate Unchanged

Predicted Opening Price for ProQR Therapeutics N.V. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$2.05 ( 0.326%) $2.05

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRQR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.34 14.51 %
R2 2.23 9.09 %
R1 2.16 5.74 %
Current price: 2.05
Support S1 1.94 -5.09 %
S2 1.87 -8.44 %
S3 1.76 -13.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.50 22.25 %
R2 2.12 3.67 %
R1 2.09 2.20 %
Current price 2.05
Support S1 1.94 -5.13%
S2 1.93 -5.62%
S3 1.90 -7.09%

FAQ

What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
The ProQR Therapeutics N.V. stock holds several negative signals and despite the positive trend, we believe ProQR Therapeutics N.V. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the 2024-04-15, the price of an ProQR Therapeutics N.V. (PRQR) share was $2.05.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.29 and the 52-week low is $1.11.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the 2024-04-15, the market capitalization of ProQR Therapeutics N.V. is 165.271M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is May 21, 2024.
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT